View Financial HealthPT. Polychem Indonesia 배당 및 자사주 매입배당 기준 점검 0/6PT. Polychem Indonesia 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • May 01First quarter 2026 earnings released: EPS: US$0.001 (vs US$0 in 1Q 2025)First quarter 2026 results: EPS: US$0.001 (up from US$0 in 1Q 2025). Revenue: US$32.4m (down 6.0% from 1Q 2025). Net income: US$1.91m (up US$2.93m from 1Q 2025). Profit margin: 5.9% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.공고 • Apr 26PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 02, 2026PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 02, 2026.Reported Earnings • Mar 19Full year 2025 earnings released: US$0.001 loss per share (vs US$0.003 loss in FY 2024)Full year 2025 results: US$0.001 loss per share (improved from US$0.003 loss in FY 2024). Revenue: US$144.7m (up 32% from FY 2024). Net loss: US$2.67m (loss narrowed 74% from FY 2024). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: US$0 (vs US$0.001 loss in 3Q 2024)Third quarter 2025 results: EPS: US$0 (improved from US$0.001 loss in 3Q 2024). Revenue: US$38.7m (up 52% from 3Q 2024). Net income: US$1.06m (up US$3.17m from 3Q 2024). Profit margin: 2.7% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Board Change • Oct 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Ilham Sumantri was the last independent director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공고 • May 17PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 24, 2025PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 24, 2025.Reported Earnings • Nov 01Third quarter 2024 earnings released: US$0.001 loss per share (vs US$0.001 loss in 3Q 2023)Third quarter 2024 results: US$0.001 loss per share (in line with 3Q 2023). Revenue: US$25.5m (up 25% from 3Q 2023). Net loss: US$2.10m (loss narrowed 14% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (Rp556.2b market cap, or US$36.1m).Reported Earnings • Apr 04Full year 2023 earnings released: US$0.005 loss per share (vs US$0.007 loss in FY 2022)Full year 2023 results: US$0.005 loss per share (improved from US$0.007 loss in FY 2022). Revenue: US$104.8m (down 27% from FY 2022). Net loss: US$19.1m (loss narrowed 28% from FY 2022). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.New Risk • Nov 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$8.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.9m free cash flow). Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (Rp571.7b market cap, or US$36.6m).Reported Earnings • Aug 08Second quarter 2023 earnings released: EPS: US$0 (vs US$0.002 loss in 2Q 2022)Second quarter 2023 results: EPS: US$0 (improved from US$0.002 loss in 2Q 2022). Revenue: US$25.5m (down 41% from 2Q 2022). Net loss: US$718.8k (loss narrowed 91% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 15% per year.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Bambang Husodo was the last independent director to join the board, commencing their role in 2009. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Jun 06First quarter 2022 earnings released: US$0.001 loss per share (vs US$0 in 1Q 2021)First quarter 2022 results: US$0.001 loss per share (down from US$0 in 1Q 2021). Revenue: US$45.5m (down 7.1% from 1Q 2021). Net loss: US$5.21m (down US$6.11m from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 27Full year 2021 earnings released: EPS: US$0 (vs US$0.01 loss in FY 2020)Full year 2021 results: EPS: US$0 (up from US$0.01 loss in FY 2020). Revenue: US$190.2m (up 25% from FY 2020). Net income: US$756.3k (up US$39.4m from FY 2020). Profit margin: 0.4% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 14% per year, which means it is performing significantly worse than earnings.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. 1 independent director (3 non-independent directors). Independent Director Tarunkumar Pal was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Jun 18Full year 2020 earnings released: US$0.01 loss per share (vs US$0.008 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$152.7m (down 35% from FY 2019). Net loss: US$38.7m (loss widened 31% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Dec 21New 90-day high: Rp178The company is up 52% from its price of Rp117 on 23 September 2020. The Indonesian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 45% over the same period.Is New 90 Day High Low • Nov 05New 90-day high: Rp150The company is up 42% from its price of Rp106 on 07 August 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 07New 90-day high: Rp133The company is up 30% from its price of Rp102 on 09 July 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 4.0% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ADMG 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ADMG 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장PT. Polychem Indonesia 배당 수익률 vs 시장ADMG의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ADMG)n/a시장 하위 25% (ID)1.1%시장 상위 25% (ID)6.2%업계 평균 (Chemicals)0.7%분석가 예측 (ADMG) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ADMG 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ADMG 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 ADMG 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: ADMG 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YID 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/19 09:13종가2026/07/17 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PT. Polychem Indonesia Tbk는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 01First quarter 2026 earnings released: EPS: US$0.001 (vs US$0 in 1Q 2025)First quarter 2026 results: EPS: US$0.001 (up from US$0 in 1Q 2025). Revenue: US$32.4m (down 6.0% from 1Q 2025). Net income: US$1.91m (up US$2.93m from 1Q 2025). Profit margin: 5.9% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
공고 • Apr 26PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 02, 2026PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 02, 2026.
Reported Earnings • Mar 19Full year 2025 earnings released: US$0.001 loss per share (vs US$0.003 loss in FY 2024)Full year 2025 results: US$0.001 loss per share (improved from US$0.003 loss in FY 2024). Revenue: US$144.7m (up 32% from FY 2024). Net loss: US$2.67m (loss narrowed 74% from FY 2024). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 04Third quarter 2025 earnings released: EPS: US$0 (vs US$0.001 loss in 3Q 2024)Third quarter 2025 results: EPS: US$0 (improved from US$0.001 loss in 3Q 2024). Revenue: US$38.7m (up 52% from 3Q 2024). Net income: US$1.06m (up US$3.17m from 3Q 2024). Profit margin: 2.7% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Board Change • Oct 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Ilham Sumantri was the last independent director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • May 17PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 24, 2025PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 24, 2025.
Reported Earnings • Nov 01Third quarter 2024 earnings released: US$0.001 loss per share (vs US$0.001 loss in 3Q 2023)Third quarter 2024 results: US$0.001 loss per share (in line with 3Q 2023). Revenue: US$25.5m (up 25% from 3Q 2023). Net loss: US$2.10m (loss narrowed 14% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.
New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (Rp556.2b market cap, or US$36.1m).
Reported Earnings • Apr 04Full year 2023 earnings released: US$0.005 loss per share (vs US$0.007 loss in FY 2022)Full year 2023 results: US$0.005 loss per share (improved from US$0.007 loss in FY 2022). Revenue: US$104.8m (down 27% from FY 2022). Net loss: US$19.1m (loss narrowed 28% from FY 2022). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
New Risk • Nov 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$8.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.9m free cash flow). Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (Rp571.7b market cap, or US$36.6m).
Reported Earnings • Aug 08Second quarter 2023 earnings released: EPS: US$0 (vs US$0.002 loss in 2Q 2022)Second quarter 2023 results: EPS: US$0 (improved from US$0.002 loss in 2Q 2022). Revenue: US$25.5m (down 41% from 2Q 2022). Net loss: US$718.8k (loss narrowed 91% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 15% per year.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Bambang Husodo was the last independent director to join the board, commencing their role in 2009. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jun 06First quarter 2022 earnings released: US$0.001 loss per share (vs US$0 in 1Q 2021)First quarter 2022 results: US$0.001 loss per share (down from US$0 in 1Q 2021). Revenue: US$45.5m (down 7.1% from 1Q 2021). Net loss: US$5.21m (down US$6.11m from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 27Full year 2021 earnings released: EPS: US$0 (vs US$0.01 loss in FY 2020)Full year 2021 results: EPS: US$0 (up from US$0.01 loss in FY 2020). Revenue: US$190.2m (up 25% from FY 2020). Net income: US$756.3k (up US$39.4m from FY 2020). Profit margin: 0.4% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 14% per year, which means it is performing significantly worse than earnings.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. 1 independent director (3 non-independent directors). Independent Director Tarunkumar Pal was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Jun 18Full year 2020 earnings released: US$0.01 loss per share (vs US$0.008 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$152.7m (down 35% from FY 2019). Net loss: US$38.7m (loss widened 31% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Dec 21New 90-day high: Rp178The company is up 52% from its price of Rp117 on 23 September 2020. The Indonesian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 45% over the same period.
Is New 90 Day High Low • Nov 05New 90-day high: Rp150The company is up 42% from its price of Rp106 on 07 August 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 07New 90-day high: Rp133The company is up 30% from its price of Rp102 on 09 July 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 4.0% over the same period.